Nordhealth As (NORDH)

Currency in NOK
36.60
0.00(0.00%)
Real-time Data·
NORDH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
NORDH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
35.2036.60
52 wk Range
32.0045.80
Key Statistics
Prev. Close
36.6
Open
35.2
Day's Range
35.2-36.6
52 wk Range
32-45.8
Volume
-
Average Volume (3m)
12.41K
1-Year Change
4.57%
Book Value / Share
10.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NORDH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
46.18
Upside
+26.17%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Nordhealth As News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Nordhealth As Company Profile

Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychotherapists; EasyPractice, a PMS for therapists; and various PMS for veterinarians under the Vetserve, Sanimalis, Vetvision, and Vetera names. The company’s products comprise Nordhealth Connect, a communication platform for patients and healthcare professionals; and Navisec, a digital learning environment for training and orientation. In addition, it offers services related to implementation of the SaaS systems, such as consultancy services, education, and data conversion. Further, the company provides nordhealth.fi, a consumer booking portal. The company was founded in 2001 and is based in Oslo, Norway.

Employees
439
Market
Norway

Nordhealth As Earnings Call Summary for Q2/2025

  • Q2 2025 revenue up 5.4% YoY to €12.9M; recurring revenue grew 13.5%, now 87.7% of total
  • Adjusted EBITDA minus CapEx negative €1M; stock dipped 2.79% post-earnings
  • Full-year recurring revenue growth guidance 12-17%; adjusted EBITDA minus CapEx forecast -€4M to -€2M
  • Heavy investment in AI and platform migrations; large enterprise rollouts expected H2 2025 and 2026
  • Competitive pressures and negative EBITDA pose challenges; company maintains strong liquidity with 2.37 current ratio
Last Updated: 19/08/2025, 16:36
Read Full Transcript

Compare NORDH to Peers and Sector

Metrics to compare
NORDH
Peers
Sector
Relationship
P/E Ratio
−26.2x−2.8x−0.6x
PEG Ratio
96.820.030.00
Price/Book
3.6x1.5x2.6x
Price / LTM Sales
5.1x2.8x3.3x
Upside (Analyst Target)
25.6%30.1%39.0%
Fair Value Upside
Unlock17.1%4.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 46.18
(+26.17% Upside)

Earnings

Latest Release
Aug 19, 2025
EPS / Forecast
-0.04 / --
Revenue / Forecast
12.86M / --
EPS Revisions
Last 90 days

NORDH Income Statement

FAQ

What Stock Exchange Does Nordhealth As Trade On?

Nordhealth As is listed and trades on the Oslo Stock Exchange stock exchange.

What Is the Stock Symbol for Nordhealth As?

The stock symbol for Nordhealth As is "NORDH."

What Is the Nordhealth As Market Cap?

As of today, Nordhealth As market cap is 2.77B.

What Is Nordhealth As's Earnings Per Share (TTM)?

The Nordhealth As EPS (TTM) is -0.12.

From a Technical Analysis Perspective, Is NORDH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Nordhealth As Stock Split?

Nordhealth As has split 0 times.

How Many Employees Does Nordhealth As Have?

Nordhealth As has 439 employees.

What is the current trading status of Nordhealth As (NORDH)?

As of 26 Aug 2025, Nordhealth As (NORDH) is trading at a price of 36.60, with a previous close of 36.60. The stock has fluctuated within a day range of 35.20 to 36.60, while its 52-week range spans from 32.00 to 45.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.